YZYuwei Zhang

Yuwei Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yuwei Zhang has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Bo Pang

    Infectious Disease Prevention and Control Section, Shandong Center for Disease Control and Prevention, Jinan, Shandong Province, People’s Republic of China

    2 shared publications
  • Xiaolin Jiang

    School of Public Health and Health Management, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong Province, People's Republic of China; School of Public Health, Shandong Second Medical University, Weifang, Shandong Province, People's Republic of China; Shandong Center for Disease Control and Prevention, Jinan, Shandong Province, People's Republic of China

    2 shared publications
  • Caiyun Chang

    Institute for Infectious Disease Control, Jinan Center for Disease Control and Prevention, Jinan, Shandong Province, People’s Republic of China

    1 shared publication
  • Jianxing Wang

    Infectious Disease Prevention and Control Section, Shandong Center for Disease Control and Prevention, Jinan, Shandong Province, China

    1 shared publication
  • Jinzhong Zhang

    Liaocheng Center for Disease Control and Prevention, Liaocheng, Shandong Province, China

    1 shared publication
  • Lianxiang Zhao

    School of Public Health and Management, Binzhou Medical University, Yantai, Shandong Province, China

    1 shared publication

Latest Publications

  • Open Access

    Transcriptome Profiles Characteristics of the Peripheral Immune in Patients with Severe Fever with Thrombocytopenia Syndrome

    by Yuwei Zhang, Qingshuai Sun, Tao Liu, Caiyun Chang, Xiangjuan Chen, Qing Duan, Zixuan Wen, Xiaomei Zhang, Bo Pang, Xiaolin Jiang

    Purpose: Severe fever with thrombocytopenia syndrome (SFTS) is an acute viral infection disease with a high mortality, but there are no specific effective drugs or vaccines available for use. To develop effective treatment methods, more basic researches are urgently needed to elucidate the response mechanisms of patients. Patients and Methods: Here, we conducted the transcriptomic analysis of peripheral immunity in 14 SFTS patients, ranging from moderate infection to severe and fatal disease. Results: The results showed orderly cytokine signaling pathway modulation in moderate patients, cellular immunosuppression in severe patients, and significant dysregulation of the inflammatory response and coagulation dysfunction characteristic of deceased patients. In addition, WGCNA further showed a significant positive correlation between fatal outcomes and B cell and immunoglobulin mediated immune function modules, as well as a significant negative correlation with coagulation function modules. Conclusion: Overall, our research findings systematically observed potential immune mechanisms underlying clinical symptom heterogeneity and noteworthily revealed multiple signaling pathways leading to coagulation dysfunction in fatal outcomes, not just related to decreased platelet count, which can further elucidate the interaction between viruses and hosts and contribute to clinical treatment.


  • Open Access

    Neutralization of SARS-CoV-2 omicron after BBIBP-CorV and ZF2001 booster vaccination

    by Yuwei Zhang, Xingyu Guo, Shanshan Han, Mingxiao Yao, Lin Zhang, Lianxiang Zhao, Jinzhong Zhang, Xiangkun Jiang, Shu Zhang, Bo Pang, et al.